Coya Therapeutics COYA
NASDAQ COYA
$4.00 -0.14 (-3.29%)
As of: Oct 23, 2026 · 2:46 PM EDT

Coya Therapeutics (COYA) Selling, General & Administrative (2022 - 2026)

Updated

Coya Therapeutics (COYA) reported Selling, General & Administrative of $2.26 million for Q2 2026, down 22.4% from $2.91 million a year earlier and down 40.4% from the prior quarter.

Analysis

Coya Therapeutics (COYA) Selling, General & Administrative (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Coya Therapeutics' Selling, General & Administrative came in at $11.86 million, up 18.9% year-over-year; for FY2025, it was $11.45 million, up 28.9% from FY2024.

  • Selling, General & Administrative has increased for four consecutive years, with a four-year compound annual growth rate of 49.2% (FY2021 to FY2025).
  • By year, Selling, General & Administrative came in at $8.89 million in FY2024 (+13.4%), $7.83 million in FY2023 (+61.6%), $4.85 million in FY2022 (+109.6%) and $2.31 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Selling, General & Administrative since Q4 2024.
  • Year over year, Selling, General & Administrative gained in six of the last eight quarters, with growth averaging 17.3%.
  • The high point for year-over-year Selling, General & Administrative in five years was Q4 2023 (growth of 164.6%); the low point was Q2 2026 (a decline of 22.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.78 million (Q1 2026), $3.27 million (Q4 2025) and $2.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,124.59 Bn 1,093.18 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 634.91 Bn 554.77 Bn 17.30 Bn 6.29 Bn
3 AbbVie 505.42 Bn 478.53 Bn 12.70 Bn 3.63 Bn
4 Merck 357.53 Bn 311.91 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 289.90 Bn 253.89 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 264.89 Bn 238.58 Bn 12.86 Bn 5.65 Bn
7 Amgen 237.79 Bn 193.19 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.74 Bn 168.94 Bn 6.22 Bn 1.92 Bn
9 Pfizer 171.08 Bn 117.73 Bn 10.94 Bn 3.41 Bn
10 Coya Therapeutics 93.93 Mn -74.95 Mn - 2.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.26 Mn
Mar 31, 2026 3.78 Mn
Dec 31, 2025 3.27 Mn
Sep 30, 2025 2.56 Mn
Jun 30, 2025 2.91 Mn
Mar 31, 2025 2.71 Mn
Dec 31, 2024 2.14 Mn
Sep 30, 2024 2.22 Mn
Jun 30, 2024 2.09 Mn
Mar 31, 2024 2.44 Mn
Dec 31, 2023 2.38 Mn
Sep 30, 2023 1.96 Mn
Jun 30, 2023 1.83 Mn
Mar 31, 2023 1.66 Mn
Dec 31, 2022 898,646.00
Sep 30, 2022 1.24 Mn
Jun 30, 2022 1.99 Mn
Mar 31, 2022 717,524.00
API Access

Coya Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=COYA&period=max&api_key=YOUR_API_KEY